Gluskin Sheff + Associates Inc. is one of Canada's pre-eminent wealth management firms, managing over $8.5 billion on behalf of high net worth private clients, estates, trusts and institutional investors.
TORONTO, April 7, 2016 /CNW/ - Gluskin Sheff + Associates Inc. (the "Company") announced today that Jeremy Freedman has indicated his intention to retire as President & Chief Executive Officer and a director of the Company effective June 30, 2016, the ...
Gluskin Sheff + Associates logo Gluskin Sheff + Associates Inc (TSE:GS) had its price target dropped by research analysts at RBC Capital from C$21.00 to C$20.00 in a research report issued on Wednesday, Marketbeat reports.
Gluskin Sheff + Associates logo Gluskin Sheff + Associates Inc (TSE:GS) has been given a consensus recommendation of “Buy” by the eight ratings firms that are currently covering the company, MarketBeat reports.
Allergan logo Gluskin Sheff & Assoc Inc. cut its stake in Allergan, Inc. (NYSE:AGN) by 50.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
TORONTO, April 15, 2016 /CNW/ - Gluskin Sheff + Associates Inc. (the "Company") announced today its estimated Assets Under Management ("AUM") as at March 31, 2016, and the components of the change in AUM.